Open original FDA record ↗Recall record
- FDA identifier
- Z-0762-2023
- Company in FDA record
- Baxter Healthcare Corporation
- FDA classification date
- Dec 22, 2022
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Reports of Polyurethane Displacement in the dialyzer, and might be identified as a blood leak
Source facts
- Action
- Baxter Healthcare notified healthcare facilities on 11/23/2022 and home patients on 11/29/2022, via first class mail. Consignees were instructed to be aware of the difference in appearances between Polyurethane Displacement and an Internal Blood Leak and ensure staff is also aware. Additionally, consignees were instructed that if there is a blood leak alarm, to follow your clinical practice to stop treatment, and if only the Polyurethane Displacement is observed, to continue use of the dialyzer. Consignees were asked to acknowledge receipt of the notification by completing and returning the response form.
- Initiated
- 2022-11-23
- Root cause
- Process control
- Distribution
- Worldwide distribution - US Nationwide and the countries of Canada, China, Australia, New Zealand, Austria, Egypt, France, Germany, Ireland, Italy, Morocco, Qatar, Saudi Arabia, South Africa, Spain, United Kingdom, Bahamas, Barbados, Belize, Bermuda, Colombia, Dominican Republic, Ecuador, Guatemala, Honduras, Mexico, Panama, St. Thomas, Trinidad and Tobago.
- Recall number
- Z-0762-2023
- Recall status
- Open, Classified
- CDRH record ID
- 197274
- FDA classified
- 2022-12-22
- Recall event number
- 91223